Skip to main content
Tech.euFundingExplorerBeta

Breye Therapeutics

Denmark-based clinical-stage biopharmaceutical company

Total raised
€4.0M
€4,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-11
latest 2022-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood16
base rate 44% for Seed
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2022-11-11Seed€4.0MNovo Holdings,Sound BioventuresView deal →

Related news

Similar companies

same sector or country